Huntexil (pridopidine) / Prilenia  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Huntexil (pridopidine) / Prilenia
MermaiHD, NCT00665223: A Study of Treatment With Pridopidine (ACR16) in Participants With Huntington's Disease

Completed
3
437
Europe
ACR16, Pridopidine, Placebo
Teva Branded Pharmaceutical Products R&D, Inc.
Huntington's Disease
06/10
06/10
NCT04556656 / 2020-002822-10: PRidopidine's Outcome On Function in Huntington Disease, PROOF- HD

Active, not recruiting
3
499
Europe, Canada, US, RoW
Pridopidine, Placebo
Prilenia
Huntington Disease
03/23
03/24

Download Options